203 RISK AND PROTECTIVE FACTORS OF GASTROESOPHAGEAL REFLUX DISEASE AFTER PERORAL ENDOSCOPIC MYOTOMY
N Fukushima, H. Kashiwagi, Fumiaki Yano(Jikei University School of Medicine), Takahiro Masuda(Jichi Medical University), Noriyuki Omura, Yuki Sakashita(Jikei University School of Medicine), K Tsuboi, Norio Mitsumori(Jikei University School of Medicine), M Hoshino, S Akimoto(Creighton University), Shutaro Yamamoto
Cited by 0
Related Papers
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
|American Journal of Physiology-Renal Physiology|2012|158
Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume
|Physiological Reports|2020|135